SCHEMBL4960036

SCHEMBL4960036

N#Cc1c(NC(=O)C2CC2c2cccs2)sc2c1CCNC2

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.43
HPGD P15428 5/20 0.43
POLB P06746 4/20 0.43
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
GAA P10253 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 3/20 0.40
MAPK10 P53779 1/20 0.39
KDM4E B2RXH2 1/20 0.39
THRB P10828 1/20 0.39
APEX1 P27695 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894559 0.85 ALDH1A1 (0.47) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL2894032 0.84 ALDH1A1 (0.44) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4961044 0.84 ALDH1A1 (0.48) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4964396 0.83 MAPK10 (0.46) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4960995 0.82 MAPK10 (0.47) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4963443 0.82 ALDH1A1 (0.44) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4961167 0.82 ALDH1A1 (0.45) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL2895762 0.81 APEX1 (0.43) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4961190 0.81 SMN1; SMN2 (0.48) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL4963439 0.81 ALDH1A1 (0.43) ALDH1A1HPGDPOLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896484-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-12 EP disclosed
WO-2006125813-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed